FDA-Approved Tedizolid Phosphate Prevents Cisplatin-Induced Hearing Loss Without Decreasing Its Anti-tumor Effect

Zhiwei Yao(Tianjin Medical University General Hospital), Xiaolong Fu(Shandong First Medical University)
Journal of the Association for Research in Otolaryngology
April 15, 2024
Cited by 3


Related Papers